Resolving the Mystery of Corticotropinoma using Radiolabeled V1b Receptor Antagonist

被引：0
|
作者：
Pandey, Somit [1 ]
Walia, Rama [1 ]
Gill, Gurvinder [1 ]
Rana, Nivedita [1 ]
Pandav, Kumud [1 ]
Kumar, Rajender [1 ]
Mittal, Bhagwant [1 ]
Shukla, Jaya [1 ]
机构：
[1] Postgrad Inst Med Educ & Res, Chandigarh, India
来源：
JOURNAL OF NUCLEAR MEDICINE | 2024年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
242576
引用
收藏
页数：3
相关论文
共 50 条
  • [21] ANC-501-A Novel V1b Receptor Antagonist: Results of a Personalized Phase 2 Trial in MDD
    Kanes, Stephen
    Dev, Vikram
    Wilson, Ellis
    Kelly, Noel
    Perera, Philip
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 206 - 207
  • [22] Insulin hypersensitivity in mice lacking the V1b vasopressin receptor
    Fujiwara, Yoko
    Hiroyama, Masami
    Sanbe, Atsushi
    Aoyagi, Toshinori
    Birumachi, Jun-ichi
    Yamauchi, Junji
    Tsujimoto, Gozoh
    Tanoue, Akito
    JOURNAL OF PHYSIOLOGY-LONDON, 2007, 584 (01): : 235 - 244
  • [23] Molecular modeling of vasopressin receptor and in silico screening of V1b receptor antagonists
    Hagiwara, Yohsuke
    Ohno, Kazuki
    Kamohara, Masazumi
    Takasaki, Jun
    Watanabe, Toshihiro
    Fukunishi, Yoshifumi
    Nakamura, Haruki
    Orita, Masaya
    EXPERT OPINION ON DRUG DISCOVERY, 2013, 8 (08) : 951 - 964
  • [24] PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD) ANALYSES OF ARGININE VASOPRESSIN TYPE-1B (V1B) RECEPTOR ANTAGONIST EFFECT ON CORTISOL.
    Singh, I.
    Liu, W.
    Katz, D. A.
    Awni, W. M.
    Dutta, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S87 - S87
  • [25] SELECTIVE ARGININE VASOPRESSIN V1B RECEPTOR ANTAGONIST REDUCES ALCOHOL DRINKING OF SARDINIAN ALCOHOL-PREFERRING RATS
    Zhou, Y.
    Colombo, G.
    Carai, M. A. M.
    Ho, A.
    Gessa, G. L.
    Kreek, M. J.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2009, 33 (06) : 144A - 144A
  • [26] Neurobiological basis and preclinical evidence for the anxiolytic/antidepressant potential of org 52186, a novel and selective V1B receptor antagonist
    MacSweeney, Cliona P.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 161S - 161S
  • [27] Prediction of a clinically effective dose of THY1773, a novel V1B receptor antagonist, based on preclinical data
    Inatani, Shoko
    Mizuno-Yasuhira, Akiko
    Kamiya, Makoto
    Nishino, Izumi
    Sabia, Helene D.
    Endo, Hiromi
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2021, 42 (05) : 204 - 217
  • [28] Evidence that atypical vasopressin V2 receptor in inner medulla of kidney is V1B receptor
    Saito, M
    Tahara, A
    Sugimoto, T
    Abe, K
    Furuichi, K
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 401 (03) : 289 - 296
  • [29] Glucocorticoids increase vasopressin V1b receptor coupling to phospholipase C
    Rabadan-Diehl, C
    Aguilera, G
    ENDOCRINOLOGY, 1998, 139 (07) : 3220 - 3226
  • [30] The localization of vasopressin V1B receptor in the mouse central nervous system
    Tanaka, T
    Koshimizu, T
    Hizume, M
    Tsujimoto, G
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 189P - 189P
12345